Evidence map›Paper›PMID 29299835›Full record

ArticleJournal of the American Society for Mass Spectrometry2018

A Caenorhabditis elegans Mass Spectrometric Resource for Neuropeptidomics.

Sven Van Bael, Sven Zels, Kurt Boonen, Isabel Beets, Liliane Schoofs, Liesbet Temmerman

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Journal of the American Society for Mass Spectrometry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.4field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Journal of biosciences · 2025
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. AdvancingPhilosophical transactions of the Royal Society of London. Series B, Biological sciences · 2024
    Review
  15. Article
  16. Article
  17. Article
  18. A molecular atlas of adultbioRxiv : the preprint server for biology · 2023
    Article
  19. Peptidomics.Nature reviews. Methods primers · 2023
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Sven Van BaelAnimal Physiology and Neurobiology, Department of Biology, KU Leuven (University of Leuven), Leuven, Belgium.ORCID 0000-0002-6948-1020
Sven ZelsAnimal Physiology and Neurobiology, Department of Biology, KU Leuven (University of Leuven), Leuven, Belgium.
Kurt BoonenAnimal Physiology and Neurobiology, Department of Biology, KU Leuven (University of Leuven), Leuven, Belgium.
Isabel BeetsAnimal Physiology and Neurobiology, Department of Biology, KU Leuven (University of Leuven), Leuven, Belgium.
Liliane SchoofsAnimal Physiology and Neurobiology, Department of Biology, KU Leuven (University of Leuven), Leuven, Belgium.
Liesbet TemmermanAnimal Physiology and Neurobiology, Department of Biology, KU Leuven (University of Leuven), Leuven, Belgium. Liesbet.Temmerman@kuleuven.be.ORCID 0000-0002-1249-3995
KU Leuven · BE

Funding

European Research Council ERC-ADG-340318Fonds Wetenschappelijk Onderzoek G052217NFonds Wetenschappelijk Onderzoek G069713KU Leuven C14/15/049KU Leuven PDM/16/094
6 · The paper itself

Abstract

Neuropeptides are important signaling molecules used by nervous systems to mediate and fine-tune neuronal communication. They can function as neurotransmitters or neuromodulators in neural circuits, or they can be released as neurohormones to target distant cells and tissues. Neuropeptides are typically cleaved from larger precursor proteins by the action of proteases and can be the subject of post-translational modifications. The short, mature neuropeptide sequences often entail the only evolutionarily reasonably conserved regions in these precursor proteins. Therefore, it is particularly challenging to predict all putative bioactive peptides through in silico mining of neuropeptide precursor sequences. Peptidomics is an approach that allows de novo characterization of peptides extracted from body fluids, cells, tissues, organs, or whole-body preparations. Mass spectrometry, often combined with on-line liquid chromatography, is a hallmark technique used in peptidomics research. Here, we used an acidified methanol extraction procedure and a quadrupole-Orbitrap LC-MS/MS pipeline to analyze the neuropeptidome of Caenorhabditis elegans. We identified an unprecedented number of 203 mature neuropeptides from C. elegans whole-body extracts, including 35 peptides from known, hypothetical, as well as from completely novel neuropeptide precursor proteins that have not been predicted in silico. This set of biochemically verified peptide sequences provides the most elaborate C. elegans reference neurpeptidome so far. To exploit this resource to the fullest, we make our in-house database of known and predicted neuropeptides available to the community as a valuable resource. We are providing these collective data to help the community progress, amongst others, by supporting future differential and/or functional studies. Graphical Abstract ᅟ.

Indexed as

Amino Acid SequenceAnimalsCaenorhabditis elegansCaenorhabditis elegans ProteinsChromatography, LiquidNeuropeptidesProteomicsTandem Mass SpectrometryCaenorhabditis elegans ProteinsNeuropeptidesCaenorhabditis elegansFLPFMRFamide-like peptideMass spectrometryNeuropeptideNLPPeptidomics

Identifiers

PMID29299835
OpenAlexW2782067321

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.